Wu, J., Wall, K., Fernandez, K., McGowan, C., Reyes, J. J., Sergi, Z., Sathe, S., Theeler, B., Penas-Prado, M., Ozer, B. H., Gilbert, M. R., Khan, J., Kim, J., Tyagi, M., Xi, L., Yuan, Y. (2026). Phase II trial evaluating nivolumab in patients with recurrent IDH-mutant gliomas with and without hypermutation phenotype.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2064